Comparing the clinical trial characteristics of industry–funded trials and non– industry–funded trials
Emily Hughes(Sinai Health System), Michael Fralick(University Health Network), Ashley Raudanskis(Sinai Health System), Chana A. Sacks(Harvard University), Tamara Van Bakel(Lunenfeld-Tanenbaum Research Institute), Ushma Purohit(Sinai Health System), Prachi Ray(Sinai Health System), Benazir Hodzic-Santor(Montreal Neurological Institute and Hospital)
Cited by 0
Related Papers
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections
|Annals of Internal Medicine|2019|215
Paradigm Shifts in Heart-Failure Therapy — A Timeline
|New England Journal of Medicine|2014|114
Oral Anticoagulant Utilization in the United States and United Kingdom
|Journal of General Internal Medicine|2020|79
Biochemical observations following administration of taurine to patients with epilepsy
|Brain Research|1975|68